Novavax (NVAX) Announces Positive Data from Three Studies of its Vaccine Against South African Strain
Go back to Novavax (NVAX) Announces Positive Data from Three Studies of its Vaccine Against South African StrainNovavax, Inc. (NASDAQ: NVAX) | Delayed: 4.78 -0.07 (1.44%) | |||||
---|---|---|---|---|---|---|
Previous Close | $4.85 | 52 Week High | $9.23 | |||
Open | $4.84 | 52 Week Low | $1.16 | |||
Day High | $4.79 | P/E | N/A | |||
Day Low | $4.76 | EPS | $-0.30 | |||
Volume | 3,599,522 |